Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/14/2024 | Q3 2024 | -$5.04 | $32,000 | |||
08/12/2024 | Q2 2024 | -$0.00 | $318,000 | |||
05/15/2024 | Q1 2024 | -$0.14 | $542,000 | |||
04/01/2024 | Q4 2023 | -$0.62 | $872,000 | |||
11/13/2023 | Q3 2023 | -$4.89 | $0 | |||
08/14/2023 | Q2 2023 | -$1.47 | $2,000 | |||
05/15/2023 | Q1 2023 | -$2.01 | $2,000 | |||
03/30/2023 | Q4 2022 | -$1.61 | $14,000 | |||
11/14/2022 | Q3 2022 | -$1.99 | $80,000 | |||
08/15/2022 | Q2 2022 | -$0.81 | $104,000 | |||
05/10/2022 | Q1 2022 | -$0.12 | $0.08 | 0.2 | $107,000 | |
03/28/2022 | Q4 2021 | -$0.16 | -$13.98 | -13.82 | $435,000 | |
11/10/2021 | Q3 2021 | -$0.45 | -$11.41 | -10.96 | $182,000 | |
08/12/2021 | Q2 2021 | -$0.81 | -$30.70 | -29.89 | $463,000 | |
05/13/2021 | Q1 2021 | -$0.81 | -$14.03 | -13.22 | $24.53 M | |
03/18/2021 | Q4 2020 | -$0.82 | -$38.31 | -37.49 | $14.28 M | |
11/09/2020 | Q3 2020 | -$0.72 | -$25.23 | -24.51 | $25.94 M | |
08/14/2020 | Q2 2020 | -$151.90 | $17.27 M | |||
03/31/2020 | Q1 2020 | -$9.49 | $16.83 M | |||
12/31/2019 | Q4 2019 | -$35.99 | $20.48 M |
Biora Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 10th, 2022 based off last year's report dates.
In the previous quarter, Biora Therapeutics, Inc. (:PROG) reported $-0.06403 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.12 by $0.05597.
The conference call for Biora Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Biora Therapeutics, Inc.'s latest earnings report can be read online.
Biora Therapeutics, Inc. (:PROG) has a recorded annual revenue of $4,000.
Biora Therapeutics, Inc. (:PROG) has a recorded net income of $4,000. Biora Therapeutics, Inc. has generated $-7.87 earnings per share over the last four quarters.
Biora Therapeutics, Inc. (:PROG) has a price-to-earnings ratio of -0.03 and price/earnings-to-growth ratio is 0.01.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED